Ohcanbohtosat - Henk‐Jan Guchelaar

Aiddostahte ozu
  1. 1
    Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients

    Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients Dahkki Romy Mosch, Henk‐Jan Guchelaar

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms

    The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms Dahkki Hendrikus Bernhard Bouwman, Henk‐Jan Guchelaar

    Almmustuhtton 2024
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis

    Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis Dahkki Judith A.M. Wessels, T. Huizinga, Henk‐Jan Guchelaar

    Almmustuhtton 2007
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands

    Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands Dahkki Paul CD Bank, Jesse J. Swen, Henk‐Jan Guchelaar

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

    Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines Dahkki Lisanne E. N. Manson, Jesse J. Swen, Henk‐Jan Guchelaar

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Clinical development of gene- and cell-based therapies: overview of the European landscape

    Clinical development of gene- and cell-based therapies: overview of the European landscape Dahkki Sofieke de Wilde, Henk‐Jan Guchelaar, Maarten L. Zandvliet, Pauline Meij

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time

    Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time Dahkki Emma C. Hulshof, Maarten J. Deenen, Henk‐Jan Guchelaar, Hans Gelderblom

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

    Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review Dahkki Sylvia D. Klomp, Martijn L. Manson, Henk‐Jan Guchelaar, Jesse J. Swen

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Technologies for Pharmacogenomics: A Review

    Technologies for Pharmacogenomics: A Review Dahkki Maaike van der Lee, Marjolein Kriek, Henk‐Jan Guchelaar, Jesse J. Swen

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

    Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice Dahkki Alireza Tafazoli, Henk‐Jan Guchelaar, Wojciech Miltyk, Adam Krętowski, Jesse J. Swen

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review

    3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review Dahkki Iris Lafeber, Elisabeth J. Ruijgrok, Henk‐Jan Guchelaar, Kirsten J. M. Schimmel

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review

    Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review Dahkki Jara M. Baas, L. L. Krens, Henk‐Jan Guchelaar, Hans Morreau, Hans Gelderblom

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Lapatinib for Advanced or Metastatic Breast Cancer

    Lapatinib for Advanced or Metastatic Breast Cancer Dahkki Frans L. Opdam, Henk‐Jan Guchelaar, Jos H. Beijnen, Jan H.M. Schellens

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)

    Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation pr... Dahkki Katja S. Just, Michael Steffens, Jesse J. Swen, George P. Patrinos, Henk‐Jan Guchelaar, Julia Stingl

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    The Risk of Cancer in Users of Statins

    The Risk of Cancer in Users of Statins Dahkki Matthijs R. Graaf, Annette B. Beiderbeck, Toine C. G. Egberts, Dick J. Richel, Henk‐Jan Guchelaar

    Almmustuhtton 2004
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

    Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options? Dahkki Jonathan E. Knikman, Hans Gelderblom, Jos H. Beijnen, Annemieke Cats, Henk‐Jan Guchelaar, Linda M. Henricks

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Liver and kidney function in patients with Covid‐19 treated with remdesivir

    Liver and kidney function in patients with Covid‐19 treated with remdesivir Dahkki Sylvia A. van Laar, Mark de Boer, Kim B. Gombert‐Handoko, Henk‐Jan Guchelaar, J. Zwaveling

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study

    Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study Dahkki E.R. Koomen, Arjen Joosse, Ron M. C. Herings, M. K. Casparie, Henk‐Jan Guchelaar, Tamar Nijsten

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Low literacy and written drug information: information-seeking, leaflet evaluation and preferences, and roles for images

    Low literacy and written drug information: information-seeking, leaflet evaluation and preferences, and roles for images Dahkki Mara M. van Beusekom, Petronella Grootens‐Wiegers, Mark Bos, Henk‐Jan Guchelaar, Jos M. van den Broek

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review

    The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review Dahkki Mara M. van Beusekom, Anne H. Kerkhoven, Mark Bos, Henk‐Jan Guchelaar, Jos M. van den Broek

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: